المؤلفون: Ferreira, João Pedro, Packer, Milton, Butler, Javed, Filippatos, Gerasimos, Pocock, Stuart, J., Januzzi, James, L., Sattar, Naveed, Maldonado, Sandra González, Panova-Noeva, Marina, Sumin, Mikhail, Masson, Serge, Anker, Stefan, D., Zannad, Faiez

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Cardiovascular R&D Centre-UnIC@RISE, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Internal Medicine Department, Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Baylor University Medical Center, Baylor College of Medecine, Imperial College London, Baylor Scott & White Research Institute (BSWRI), University of Mississippi Medical Center (UMMC), “Attikon” University Hospital, National and Kapodistrian University of Athens (NKUA), London School of Hygiene and Tropical Medicine (LSHTM), Massachusetts General Hospital Boston, Baim Institute for Clinical Research Boston MA, University of Glasgow, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Roche Diagnostics International Ltd, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), The EMPEROR-Reduced and Preserved trials were funded by Boehringer Ingelheim and Eli Lilly (EMPEROR-Reduced ClinicalTrials.gov number, NCT03057977 and EMPEROR-Preserved ClinicalTrials.gov number, NCT03057951)

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04317427Test ; European Journal of Heart Failure, 2023, ⟨10.1002/ejhf.3078⟩.

مصطلحات موضوعية: Growth differentiation factor-15 Heart failure Empagliflozin Metformin, Growth differentiation factor-15, Heart failure, Empagliflozin, Metformin, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37964408; hal-04317427; https://hal.univ-lorraine.fr/hal-04317427Test; https://hal.univ-lorraine.fr/hal-04317427/documentTest; https://hal.univ-lorraine.fr/hal-04317427/file/European%20J%20of%20Heart%20Fail%20-%202023%20-%20Ferreira%20-%20Growth%20differentiation%20factor%E2%80%9015%20and%20the%20effect%20of%20empagliflozin%20in%20heart.pdfTest; PUBMED: 37964408

الإتاحة: https://doi.org/10.1002/ejhf.3078Test
https://hal.univ-lorraine.fr/hal-04317427Test
https://hal.univ-lorraine.fr/hal-04317427/documentTest
https://hal.univ-lorraine.fr/hal-04317427/file/European%20J%20of%20Heart%20Fail%20-%202023%20-%20Ferreira%20-%20Growth%20differentiation%20factor%E2%80%9015%20and%20the%20effect%20of%20empagliflozin%20in%20heart.pdfTest

المؤلفون: Wischhusen, Jörg, Melero, Ignacio, Fridman, Wolf, Herman

المساهمون: University Hospital of Würzburg, Center for Applied Medical Research Plamplona (CIMA), Universidad de Navarra Pamplona (UNAV), Clínica Universidad de Navarra Pamplona, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)

المصدر: ISSN: 1664-3224.

مصطلحات موضوعية: anorexia, autoimmunity, cancer, growth/differentiation factor-15 (GDF-15), immune exclusion, immunotherapy, macrophage inhibitory cytokine-1 (MIC-1), pregnancy, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32508832; hal-02878344; https://hal.sorbonne-universite.fr/hal-02878344Test; https://hal.sorbonne-universite.fr/hal-02878344/documentTest; https://hal.sorbonne-universite.fr/hal-02878344/file/fimmu-11-00951.pdfTest; PUBMED: 32508832; PUBMEDCENTRAL: PMC7248355

الإتاحة: https://doi.org/10.3389/fimmu.2020.00951Test
https://hal.sorbonne-universite.fr/hal-02878344Test
https://hal.sorbonne-universite.fr/hal-02878344/documentTest
https://hal.sorbonne-universite.fr/hal-02878344/file/fimmu-11-00951.pdfTest

المؤلفون: Verdonschot, Job A. J., Ferreira, João Pedro, Pellicori, Pierpaolo, Brunner-La Rocca, Hans-Peter, Clark, Andrew L., Cosmi, Franco, Cuthbert, Joe, Girerd, Nicolas, Mariottoni, Beatrice, Petutschnigg, Johannes, Rossignol, Patrick, Cleland, John G. F., Zannad, Faiez, Heymans, Stephane R. B., HOMAGE \\'Heart Omics in AGEing\\' consortium

المساهمون: Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University of Glasgow, Institute of Health and Wellbeing, University of Glasgow-Gartnavel General Hospital, Glasgow, Robertson Centre for Biostatistics & Clinical Trials Unit, University of Hull [United Kingdom], Castle Hill Hospital, Cortona Hospital, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Charité Campus Virchow-Klinikum (CVK), Berlin Institute of Health (BIH), German Center for Cardiovascular Research (DZHK), The research leading to these results has received funding from the EuropeanUnion Commission’s Seventh Framework programme under Grant AgreementNo. 305507 (HOMAGE). S.H: This manuscript has been possible thanks to thesupport of the Netherlands Cardiovascular Research Initiative, an initiativewith support of the Dutch Heart Foundation, CVON2016-Early HFPEF, 2015-10,CVON She-PREDICTS, Grant 2017-21., European Project: 305507, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), BOZEC, Erwan, HOMAGE (Heart Omics in Ageing consortium) - 305507 - INCOMING, RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9)

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, BioMed Central, 2021, 20 (1), pp.163. ⟨10.1186/s12933-021-01357-9⟩
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Cardiovascular Diabetology, 20(1):163. BioMed Central Ltd

مصطلحات موضوعية: Male, Proteomics, Cardiac & Cardiovascular Systems, Time Factors, Proteome, Diabetic Cardiomyopathies, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Spironolactone, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Natriuretic peptide, Prospective Studies, Original Investigation, Mineralocorticoid Receptor Antagonists, 0303 health sciences, Diabetes, Blood Proteins, GROWTH-DIFFERENTIATION FACTOR-15, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Treatment Outcome, Biomarker (medicine), Female, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, medicine.medical_specialty, medicine.drug_class, Heart failure, Risk Assessment, 03 medical and health sciences, Endocrinology & Metabolism, INFLAMMATION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Predictive Value of Tests, Diabetes mellitus, Internal medicine, medicine, Diabetes Mellitus, Diseases of the circulatory (Cardiovascular) system, Humans, 030304 developmental biology, Aged, Proteomic Profile, Science & Technology, business.industry, Biomarker, medicine.disease, Omics, Fibrosis, Blood pressure, chemistry, RC666-701, Cardiovascular System & Cardiology, business, Biomarkers

وصف الملف: Electronic; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df652958d7e94ce09add8331ace3234fTest
https://hal.univ-lorraine.fr/hal-03320862/documentTest